HiST Pharma
Chengdu, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech firm pursuing a dual-track pipeline of small molecules and biologics for various diseases.
Oncology
Technology Platform
An integrated drug discovery platform combining computational design, high-throughput screening, and protein engineering for both small molecules and biologics.
Opportunities
Opportunity to license promising preclinical assets to larger companies seeking to bolster their early pipelines.
Risk Factors
Risk of running out of capital before achieving a meaningful valuation inflection point, such as a clinical trial start.
Competitive Landscape
Competes with countless other preclinical biotechs and research institutes for funding and partnership attention.